Ocular myasthenia caused by D-penicillamine
Schmidt, D.; Kommerell, G.
Klinische Monatsblatter für Augenheilkunde 168(3): 409-413
1976
ISSN/ISBN: 0023-2165 PMID: 966573 Document Number: 107464
This report concerns a 55-year-old woman who developed ocular myasthenia after 12 months treatment with D-Penicillamine for her rheumatoid arthritis. In the last 2 years the literature contains reports of 22 similar cases.
Document emailed within 1 workday
Related Documents
Vincent, A.; Newsom-Davis, J. 1982: Acetylcholine receptor antibody characteristics in myasthenia gravis. II. Patients with penicillamine-induced myasthenia or idiopathic myasthenia of recent onset Clinical and Experimental Immunology 49(2): 266-272Rousseau, J.J.; Dieudonne, L.G. 1980: Myasthenia gravis syndrome following administration of d-penicillamine Acta Neurologica Belgica 80(3): 165-173
Huaux, J.P.; Delreux, V. 1986: Myasthenia induced by D-penicillamine. Apropos of 2 case reports Acta Neurologica Belgica 86(5): 297-303
Gordon, R.A.; Burnside, J.W. 1977: D-Penicillamine-induced myasthenia gravis in rheumatoid arthritis Annals of Internal Medicine 87(5): 578-579
Ongerboer de Visser, B.W.; van Soesbergen, R.M. 1978: Myasthenia gravis as a complication of D-penicillamine treatment in rheumatoid arthritis Nederlands Tijdschrift Voor Geneeskunde 122(52): 2055-2058
Burke, W.J. 1975: The ocular myasthenia syndrome Proceedings of the Australian Association of Neurologists 12: 167-170
Godoy, L.; Gómez, C.; Idiáquez, J.; Gac, J.; Guevara, C. 2014: Ocular myasthenia and dysautonomia associated to thymoma Revista de Neurologia 59(8): 381-382
Agafonov, B.V.; Mozherenko, V.P.; Fialkovskiĭ, S.Iu. 1988: Ocular symptoms of myasthenia (a review) Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 88(3): 123-125
Yamada, S.; Tomita, Y. 1991: Evoked EMG in juvenile ocular myasthenia gravis No to Hattatsu 23(1): 15-19
Bao, A.; Yang, B.-y. 2014: Acupuncture for 9 cases of ocular myasthenia gravis Zhongguo Zhen Jiu 34(11): 1081-1082
Davis, T.L.; Lavin, P.J. 1989: Pseudo one-and-a-half syndrome with ocular myasthenia Neurology 39(11): 1553
Komiyama, A.; Hirayama, K.; Ito, N. 1987: Enhancement of ptosis at ocular adduction in myasthenia gravis Rinsho Shinkeigaku 27(1): 1-4
Goadsby, P.J.; Adams, R.W.; Lance, J.W. 1989: Massive benign thymoma presenting as ocular myasthenia Australian and New Zealand Journal of Medicine 19(3): 257-258
De Entrambasaguas, M.; López-Bernabé, R.; López-Alemany, M. 2007: Ocular myasthenia gravis: diagnostic aspects and evolution Revista de Neurologia 44(7): 397-403
Prieto Carles, C.; Gutiérrez Millet, V.; Barrientos, A.; Bello, I.; Gómez Tierno, A.; Navas, J.J.; Rodicio, J.L. 1982: Membranous nephropathy caused by D-penicillamine Medicina Clinica 79(4): 164-167
Kraithat, P.; Hansapinyo, L.; Patikulsila, P. 2015: Treatment Outcomes and Predictive Factors in Pediatric Ocular Myasthenia Gravis Journal of the Medical Association of Thailand 98(9): 883-888
Majumdar, J.; Mukhopadhyay, S.; Sharan, A.; Sengupta, S.; Ghosh, B. 2017: Tolosa-Hunt Syndrome and Ocular Myasthenia: A Rare Coexistence or Real Association Journal of the Association of Physicians of India 65(2): 82-84
Leeamornsiri, S.; Chirapapaisan, N.; Chuenkongkaew, W. 2011: Clinical profiles of Thai patients with ocular myasthenia gravis in Siriraj Hospital Journal of the Medical Association of Thailand 94(9): 1117-1121
Hayashi, S.; Hirose, N.; Ikeda, T.; Shigematsu, N. 1985: A case of prolonged pulmonary eosinophilia caused by D-penicillamine Nihon Kyobu Shikkan Gakkai Zasshi 23(4): 479-484
Oroszlán, G.; Sanderud, J.; Saugstad, O.D.; Lakatos, L. 1992: D-penicillamine: old drug, new indication? D-penicillamine reduced pulmonary hypertension induced by free radicals Orvosi Hetilap 133(44): 2835-2836; 2839